RTW BIO completes investment in Arix Bioscience ahead of merger
LONDON, UK: RTW BIO, a biopharmaceutical and medical technology investment company, has completed its investment in Arix Bioscience, a life sciences venture capital firm, ahead of their planned merger. RTW BIO has acquired a 25.5% stake in Arix from Acacia…